Terveystalo Oyj financials
Terveystalo Oyj
Country: FI Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
7437001AEZHLL3UEX093 Financial statements
(EUR, as reported — unscaled; 103 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €1.28B | €1.34B |
| Other income | €4.0M | €3.7M |
| Employee benefits expense | €403.5M | €427.8M |
| Operating profit (EBIT) | €137.5M | €116.1M |
| Net finance income / (cost) | -€21.2M | -€26.5M |
| Finance costs | €23.0M | €28.6M |
| Profit before tax | €116.2M | €89.6M |
| Income tax expense | €23.5M | €18.0M |
| Profit for the year | €92.6M | €71.7M |
| — attributable to owners | €92.6M | €71.7M |
| Total comprehensive income | €95.6M | €69.6M |
| Per share | ||
| Basic EPS | €0.73 | €0.57 |
| Diluted EPS | €0.73 | €0.57 |
| Free cash flow / share | €1.39 | €1.56 |
| Cash flow statement | ||
| Net cash from operating activities | €207.0M | €223.7M |
| Net cash from investing activities | -€69.6M | -€47.4M |
| Purchase of PP&E (capex) | €30.8M | €27.3M |
| Purchase of intangibles | €20.8M | €12.3M |
| Net cash from financing activities | -€126.8M | -€148.8M |
| Dividends paid | €60.8M | €38.0M |
| Lease liability payments | €48.8M | €48.4M |
| Balance sheet | ||
| Total assets | €1.44B | €1.40B |
| Non-current assets | €1.22B | €1.19B |
| Property, plant & equipment | €96.0M | €87.7M |
| Right-of-use assets | €189.5M | €182.7M |
| Intangible assets & goodwill | €838.8M | €829.4M |
| Inventories | €7.6M | €7.2M |
| Trade & other receivables | €124.2M | €135.0M |
| Cash & equivalents | €75.2M | €65.2M |
| Total equity | €584.2M | €548.2M |
| — attributable to owners | €584.2M | €548.2M |
| Non-current liabilities | €526.2M | €530.5M |
| Long-term borrowings | €332.3M | €348.5M |
| Lease liabilities (non-current) | €154.3M | €144.5M |
| Short-term borrowings | €48.8M | €29.7M |
| Lease liabilities (current) | €45.4M | €47.3M |
| Trade & other payables | €212.4M | €230.3M |
| Deferred tax liabilities | €17.6M | €18.7M |
| Derived metrics | ||
| Free cash flow | €176.2M | €196.4M |
| Operating margin | 10.8% | 8.7% |
| Net margin | 7.2% | 5.4% |
| Return on equity | 15.9% | 13.1% |
| Cash conversion ratio | 2.24× | 3.12× |
| Capex coverage | 6.72× | 8.19× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€400.0K | -€100.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | €8.4M | €4.9M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €100.0M | €106.4M |
| Adjustments For Finance Income Cost | -€21.2M | -€26.5M |
| Adjustments For Increase Decrease In Trade and Other Payables | -€17.7M | €9.6M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€200.0K | -€300.0K |
| Adjustments For Provisions | -€1.3M | €100.0K |
| Cash and Cash Equivalents Classified As Part of Disposal Group Held For Sale | €500.0K | €0 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €100.0K | €300.0K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €10.7M | €8.4M |
| Comprehensive Income Attributable To Owners of Parent | €95.6M | €69.6M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €207.7M | €208.2M |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | €326.2M | €319.7M |
| Current Provisions | €3.1M | €2.9M |
| Current Tax Assets Current | €700.0K | €900.0K |
| Current Tax Liabilities Current | €16.5M | €9.5M |
| Deferred Tax Assets | €9.3M | €7.1M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €100.0M | €106.4M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €81.1M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €0.64 | — |
| Dividends Received Classified As Investing Activities | €0 | €0 |
| Dividends Recognised As Distributions To Owners Per Share | €0.48 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €100.0K | -€100.0K |
| Equity and Liabilities | €1.44B | €1.40B |
| Finance Income | €1.8M | €2.1M |
| Gains Losses On Exchange Differences On Translation Net of Tax | €3.0M | -€2.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €20.4M | €12.4M |
| Increase Decrease In Cash and Cash Equivalents | €10.5M | €27.5M |
| Increase Decrease Through Sharebased Payment Transactions | €1.1M | €1.2M |
| Intangible Assets Other Than Goodwill | €80.3M | €82.0M |
| Interest Paid Classified As Financing Activities | €21.1M | €23.7M |
| Interest Received Classified As Operating Activities | €500.0K | €1.0M |
| Investment Accounted For Using Equity Method | €7.2M | €0 |
| Investment Property | €200.0K | €300.0K |
| Issued Capital | €100.0K | €100.0K |
| Liabilities | €856.9M | €850.2M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €4.6M | €0 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €10.0M | €0 |
| Noncurrent Payables | €20.4M | €15.5M |
| Noncurrent Provisions | €1.6M | €3.3M |
| Other Adjustments For Noncash Items | €700.0K | -€1.5M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €1.0M | €0 |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | €7.0M | €0 |
| Other Comprehensive Income | €3.0M | -€2.1M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €0 | -€100.0K |
| Other Expense By Nature | €132.1M | €143.7M |
| Other Inflows Outflows of Cash Classified As Financing Activities | €0 | -€3.8M |
| Other Noncurrent Assets | €1.7M | €700.0K |
| Other Noncurrent Receivables | €300.0K | €300.0K |
| Proceeds From Current Borrowings | €18.1M | €9.9M |
| Proceeds From Noncurrent Borrowings | €0 | €200.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €600.0K | €600.0K |
| Purchase of Investments Other Than Investments Accounted For Using Equity Method | €0 | €300.0K |
| Repayments of Current Borrowings | €15.6M | €100.1M |
| Repayments of Noncurrent Borrowings | €0 | €145.1M |
| Reserve of Exchange Differences On Translation | -€4.3M | -€7.3M |
| Retained Earnings | €110.4M | €77.9M |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | -€200.0K | €0 |
| Treasury Shares | €14.8M | €15.2M |
Methodology
Every line item above is a fact tagged in Terveystalo Oyj's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.